NCT03208725

Brief Summary

The CHAIN Network aims to identify modifiable biomedical and social factors driving the greatly increased risk of mortality among young undernourished children admitted to hospital with acute illness, as inpatients and after discharge. The study will inform priorities, risks and targeting for multi-faceted interventional trials. CHAIN is a multi-centre cohort study with a nested case control analysis of stored biological samples. Study sites are located in Africa and South Asia. Children will be recruited at admission to hospital, stratified by nutritional status. Exposures will be assessed at admission, during hospitalisation, at discharge, and at two time points after discharge. The main outcomes of interest are mortality, re-admission to hospital and failure of nutritional recovery up to 180 days after discharge. To determine community health norms, an additional sample of children living in the same communities will be enrolled and assessed at one time point only.

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
4,335

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2016

Longer than P75 for all trials

Geographic Reach
5 countries

8 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 30, 2016

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 8, 2017

Completed
4 months until next milestone

First Posted

Study publicly available on registry

July 5, 2017

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2020

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2020

Completed
Last Updated

May 20, 2020

Status Verified

May 1, 2020

Enrollment Period

3.2 years

First QC Date

March 8, 2017

Last Update Submit

May 18, 2020

Conditions

Keywords

MalnutritionHospitalizationAcute IllnessPediatricPost-discharge mortalityMortalityCohortNested case controlAntimicrobial resistanceAntibioticFeedingUndernutrition

Outcome Measures

Primary Outcomes (2)

  • Mortality

    Assessed using clinical and civil records and verbal autopsy

    Up to 30 days after admission to hospital

  • Mortality

    Assessed using clinical and civil records and verbal autopsy

    Up to 180 days after discharge from hospital

Secondary Outcomes (4)

  • Rehospitalization

    Up to 180 days after discharge from hospital

  • Change in weight-for-height z-score

    Up to 180 days after discharge from hospital

  • Change in length-for-age z-score

    Up to 180 days after discharge from hospital

  • Change in mid-upper arm circumference

    Up to 180 days after discharge from hospital

Study Arms (4)

Hospitalized children with severe wasting or kwashiorkor (SWK)

Children recruited at admission to hospital and followed up for 180 days post-discharge.

Community reference participants (CP)

Children recruited from the community who are seen a single appointment in the community.

Hospitalized children with moderate wasting (MW)

Children recruited at admission to hospital and followed up for 180 days post-discharge.

Hospitalized children without wasting (NW)

Children recruited at admission to hospital and followed up for 180 days post-discharge.

Eligibility Criteria

Age2 Months - 23 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Hospital and post-discharge cohort: Children being admitted to hospital. Community reference participants: Children living in the same communities as those recruited into the hospitalized cohort.

You may qualify if:

  • Children 2 months-23 months.
  • Admitted to hospital.
  • Planning to remain within the hospital catchment area and willing to come for specified visits during the 6 month follow up period.
  • Parent or guardian consents on child's behalf.
  • Aged 2 to 23 months
  • Living in the same community as the acutely ill children recruited.
  • Not having an acute illness requiring hospital admission
  • Absence of known, but untreated HIV or TB
  • Not admitted to hospital within the last 14 days
  • Not previously included in the study
  • Parent or guardian consents on child's behalf.

You may not qualify if:

  • Requiring immediate resuscitation at admission to hospital\*
  • Unable to tolerate oral feeds while in his/her usual state of health
  • Underlying terminal illness that in the opinion of the treating physician is likely to lead to death within 6 months (e.g., cancer, congenital heart disease)
  • Diagnosed with a condition that in the opinion of the treating physician is likely to require surgery within 6 months
  • Diagnosed chromosomal abnormality (syndromically or genetically diagnosed abnormality)
  • Primary reason for admission is poisoning, trauma or a surgical condition
  • Previously enrolled in this study
  • Sibling currently or previously enrolled in this study
  • (\* children requiring resuscitation will be defined as those with on-going cardiac or pulmonary arrest or judged to be peri-arrest by the attending physician)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (8)

Matlab Hospital

Dhaka, Chittagong, Bangladesh

Location

ICDDR,B Dhaka Hospital

Dhaka, Bangladesh

Location

Kilifi County Hospital

Kilifi, Kenya

Location

Migori County Hospital

Migori, Kenya

Location

Mbagathi District Hospital

Nairobi, Kenya

Location

Queen Elizabeth Central Hospital

Blantyre, Malawi

Location

Civil Hospital Karachi

Karachi, Pakistan

Location

Mulago Hospital

Kampala, Uganda

Location

Related Publications (3)

  • Njunge JM, Tickell K, Diallo AH, Sayeem Bin Shahid ASM, Gazi MA, Saleem A, Kazi Z, Ali S, Tigoi C, Mupere E, Lancioni CL, Yoshioka E, Chisti MJ, Mburu M, Ngari M, Ngao N, Gichuki B, Omer E, Gumbi W, Singa B, Bandsma R, Ahmed T, Voskuijl W, Williams TN, Macharia A, Makale J, Mitchel A, Williams J, Gogain J, Janjic N, Mandal R, Wishart DS, Wu H, Xia L, Routledge M, Gong YY, Espinosa C, Aghaeepour N, Liu J, Houpt E, Lawley TD, Browne H, Shao Y, Rwigi D, Kariuki K, Kaburu T, Uhlig HH, Gartner L, Jones K, Koulman A, Walson J, Berkley J. The Childhood Acute Illness and Nutrition (CHAIN) network nested case-cohort study protocol: a multi-omics approach to understanding mortality among children in sub-Saharan Africa and South Asia. Gates Open Res. 2022 Nov 3;6:77. doi: 10.12688/gatesopenres.13635.2. eCollection 2022.

  • Tickell KD, Denno DM, Saleem A, Ali A, Kazi Z, Singa BO, Otieno C, Mutinda C, Ochuodho V, Richardson BA, Asbjornsdottir KH, Hawes SE, Berkley JA, Walson JL. Enteric Permeability, Systemic Inflammation, and Post-Discharge Growth Among a Cohort of Hospitalized Children in Kenya and Pakistan. J Pediatr Gastroenterol Nutr. 2022 Dec 1;75(6):768-774. doi: 10.1097/MPG.0000000000003619. Epub 2022 Sep 20.

  • Childhood Acute Illness and Nutrition Network. Childhood Acute Illness and Nutrition (CHAIN) Network: a protocol for a multi-site prospective cohort study to identify modifiable risk factors for mortality among acutely ill children in Africa and Asia. BMJ Open. 2019 May 5;9(5):e028454. doi: 10.1136/bmjopen-2018-028454.

Related Links

Biospecimen

Retention: SAMPLES WITH DNA

Whole blood, serum, plasma, rectal swabs, faeces, urine, peripheral blood mononuclear cells, bacterial isolates, PBMCs, TLR-stimulated whole blood, urine, breast milk

MeSH Terms

Conditions

MalnutritionPneumoniaDiarrheaSepsisBacteremiaAcquired Immunodeficiency SyndromeIntestinal Diseases

Condition Hierarchy (Ancestors)

Nutrition DisordersNutritional and Metabolic DiseasesRespiratory Tract InfectionsInfectionsLung DiseasesRespiratory Tract DiseasesSigns and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and SymptomsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesBacterial InfectionsBacterial Infections and MycosesHIV InfectionsBlood-Borne InfectionsCommunicable DiseasesSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Officials

  • James A Berkley, MBBS, FRCPCH

    University of Oxford

    PRINCIPAL INVESTIGATOR
  • Judd L Wilson, MD, MPH

    University of Washington

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 8, 2017

First Posted

July 5, 2017

Study Start

November 30, 2016

Primary Completion

January 31, 2020

Study Completion

October 31, 2020

Last Updated

May 20, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

Locations